
AHR antagonist 1
CAS No. 2162982-11-6
AHR antagonist 1 ( —— )
产品货号. M20332 CAS No. 2162982-11-6
AHRantagonist 1 是一种芳基烃受体 (AHR) 拮抗剂,在人细胞系中的 IC50 为 39.9 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥373 | 有现货 |
![]() ![]() |
5MG | ¥535 | 有现货 |
![]() ![]() |
10MG | ¥948 | 有现货 |
![]() ![]() |
25MG | ¥2130 | 有现货 |
![]() ![]() |
50MG | ¥3613 | 有现货 |
![]() ![]() |
100MG | ¥5370 | 有现货 |
![]() ![]() |
500MG | ¥11259 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称AHR antagonist 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AHRantagonist 1 是一种芳基烃受体 (AHR) 拮抗剂,在人细胞系中的 IC50 为 39.9 nM。
-
产品描述AHR antagonist 1 is an aryl hydrocarbon receptor (AHR) antagonist has an IC50 of 39.9 nM in human cell line.
-
体外实验RT-PCR Cell Line:human monocytic U937 cells Concentration:1 nM-3 μM Incubation Time:Result:Regulated antagonise ligand-induced AHR gene in a dose-dependent manner.
-
体内实验Animal Model:Balb/c mice (subcutaneously CT26 cells) Dosage:30 mg/kg Administration:p.o, bid Result:Significantly decreased tumors size combinated with aPD-L1.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点AhR
-
受体AhR
-
研究领域——
-
适应症——
化学信息
-
CAS Number2162982-11-6
-
分子量401.82
-
分子式C20H17ClFN3O3
-
纯度>98% (HPLC)
-
溶解度DMSO:250 mg/mL (622.17 mM)
-
SMILESC[C@@H](CO)NC(=O)c1cc(nn(-c2cccc(F)c2)c1=O)-c1ccc(Cl)cc1
-
化学全称(S)-6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-23-dihydropyridazine-4-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ilona Gutcher Christina Kober Lars Roeseet al.Abstract 1288: Blocking tumor-associated immune suppression with BAY-218 a novel selective aryl hydrocarbon receptor (AhR) inhibitor[J].10.1158/1538-7445.AM2019-1288 Published July 2019.